Search

everythinglearnresearchcommunity

for

Search:↓

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Chicken feather gene mutation helps understand human hair disorders.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Histone modification is key in treating chronic inflammatory skin diseases.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.